SecSonar.com

NeuroPace, Inc. (NPCE)

NeuroPace, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

NeuroPace, Inc. (NPCE) is a Medical - Devices company based in US with a market capitalization of $590.8M. Revenue grew 25.1% year-over-year and free cash flow was negative at -$11.3M. This page tracks NPCE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 184 employees · IPO Apr 22, 2021

Valuation

Valuation & price

$15.36 · as of May 17, 2026 · -20.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

31.05

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$18.35$13.30$8.25Jul 25Dec 25Jul 26Jul 7, 25$10.22Jul 9, 25$10.08Jul 11, 25$9.52Jul 15, 25$9.35Jul 17, 25$9.08Jul 21, 25$9.36Jul 23, 25$9.50Jul 25, 25$8.98Jul 29, 25$8.78Jul 31, 25$8.51Aug 4, 25$8.93Aug 6, 25$8.89Aug 11, 25$8.89Aug 13, 25$9.32Aug 15, 25$8.56Aug 19, 25$8.25Aug 21, 25$8.62Aug 25, 25$8.65Aug 27, 25$8.88Aug 29, 25$9.15Sep 3, 25$9.36Sep 5, 25$9.73Sep 9, 25$9.97Sep 11, 25$10.01Sep 16, 25$9.80Sep 18, 25$10.32Sep 22, 25$10.36Sep 24, 25$10.22Sep 26, 25$10.20Sep 30, 25$10.31Oct 2, 25$10.43Oct 6, 25$10.77Oct 8, 25$11.13Oct 10, 25$10.28Oct 14, 25$10.82Oct 16, 25$10.64Oct 21, 25$10.79Oct 23, 25$10.55Oct 27, 25$10.60Oct 29, 25$10.13Oct 31, 25$9.94Nov 4, 25$9.40Nov 6, 25$12.78Nov 10, 25$13.45Nov 12, 25$13.50Nov 14, 25$12.94Nov 18, 25$13.02Nov 20, 25$13.50Nov 25, 25$16.70Nov 28, 25$16.36Dec 2, 25$16.02Dec 4, 25$16.97Dec 8, 25$16.43Dec 10, 25$16.78Dec 12, 25$16.19Dec 16, 25$15.88Dec 18, 25$15.74Dec 22, 25$16.56Dec 24, 25$16.19Dec 29, 25$15.61Jan 2, 26$15.17Jan 6, 26$16.39Jan 8, 26$16.96Jan 12, 26$16.91Jan 14, 26$16.75Jan 16, 26$16.94Jan 21, 26$16.94Jan 23, 26$16.71Jan 27, 26$15.95Jan 29, 26$15.32Feb 2, 26$15.91Feb 4, 26$16.09Feb 9, 26$15.26Feb 11, 26$14.56Feb 13, 26$15.05Feb 18, 26$14.45Feb 20, 26$14.34Feb 24, 26$14.56Feb 26, 26$15.02Mar 2, 26$14.15Mar 4, 26$13.95Mar 6, 26$14.03Mar 10, 26$14.22Mar 12, 26$14.12Mar 17, 26$13.82Mar 19, 26$13.13Mar 23, 26$13.38Mar 25, 26$13.53Mar 27, 26$13.33Mar 31, 26$13.15Apr 2, 26$14.65Apr 7, 26$14.51Apr 9, 26$14.65Apr 13, 26$14.88Apr 15, 26$15.61Apr 17, 26$16.19Apr 22, 26$16.98Apr 24, 26$16.80Apr 28, 26$16.89Apr 30, 26$16.86May 4, 26$16.90May 6, 26$18.12May 8, 26$18.35May 12, 26$15.80May 14, 26$15.79May 18, 26$15.99May 20, 26$16.27May 22, 26$16.92May 28, 26$17.39Jun 1, 26$16.51Jun 3, 26$15.88Jun 5, 26$15.74Jun 9, 26$15.96Jun 11, 26$15.84Jun 15, 26$15.37Jun 17, 26$15.16Jun 22, 26$15.37Jun 24, 26$16.22Jun 26, 26$16.47Jul 2, 26$16.14
$8.2552-week range$19.29
Loading valuation history…

Fundamentals

Key fundamentals

$590.8M

Market cap

25.1%

Revenue growth (YoY)

77.2%

Gross margin

-$11.3M

Free cash flow (USD)

$9.8M

Net debt

12.3%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$37.0MFY 2020$41.1MFY 2021$45.2MFY 2022$45.5MFY 2023$65.4MFY 2024$79.9MFY 2025$100.0M
$37M$100M

Free cash flow by year

2019 → 2025

FY 2019$-25.5MFY 2020$-21.7MFY 2021$-25.0MFY 2022$-37.5MFY 2023$-19.9MFY 2024$-18.3MFY 2025$-11.3M
-$25.5M-$11.3M

Gross margin by year

2021 → 2025

FY 202174.0%FY 202271.4%FY 202373.6%FY 202473.9%FY 202577.2%
74.0%77.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing

Questions

Frequently asked questions

What is NeuroPace, Inc.'s market cap?

NeuroPace, Inc. (NPCE) has a market capitalization of $590.8M.

What is NPCE's P/E ratio?

A meaningful P/E ratio is not available for NPCE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NPCE's price-to-book (P/B) ratio?

NPCE trades at 31.05 times book value per share.

Are insiders buying NPCE stock?

SEC Form 4 filings show no open-market insider buys at NeuroPace, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

BVS

Bioventus Inc.

$580.6M

CERS

Cerus Corporation

$612.8M

BWAY

BrainsWay Ltd.

$613.4M

TCMD

Tactile Systems Technology, Inc.

$560.5M

CTKB

Cytek Biosciences, Inc.

$551.6M

SIBN

SI-BONE, Inc.

$631.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.